Search alternatives:
question » questions

1
by Abernethy, Amy Pickar, McCrory, Douglas C.
Published 2005
AHRQ Technology Assessment Program
...) approved thalidomide for use in treating leprosy (Hansen's disease); it is not currently FDA-approved...

2
by Abernethy, Amy Pickar, McCrory, Douglas C.
Published 2005
AHRQ Technology Assessment Program
...) approved thalidomide for use in treating leprosy (Hansen's disease); it is not currently FDA-approved...

3
by Schoelles, Karen M.
Published 2005
Agency for Healthcare Research and Quality
... for each question. Search MEDLINE and other suitable databases containing primary studies and review...

4
by Schoelles, Karen M.
Published 2005
Agency for Healthcare Research and Quality
... for each question. Search MEDLINE and other suitable databases containing primary studies and review...

5
by Matchar, David B.
Published 2006
AHRQ Technology Assessment Program
...) was designed to respond to three specific questions posed by the Centers for Medicare and Medicaid Services...

6
by Matchar, David B.
Published 2006
AHRQ Technology Assessment Program
...) was designed to respond to three specific questions posed by the Centers for Medicare and Medicaid Services...

7
Published 2005
Agency for Healthcare Research and Quality
..., developed five Key Questions to be addressed. These questions are as follows: 1. Do freestanding cardiac...

8
Published 2005
Agency for Healthcare Research and Quality
..., developed five Key Questions to be addressed. These questions are as follows: 1. Do freestanding cardiac...

9
by Raman, Gowri
Published 2011
Agency for Healthcare Research and Quality, Technology Assessment Program
... cells by directly transmitting the electrical impulses to the acoustic nerve. Currently, most patients...

10
by Matchar, David B.
Published 2006
AHRQ, Technology Assessment Program
... imaging tests (NITs) for coronary artery disease. In particular, we focus on six key questions provided...

11
by Ratko, Thomas, Belinson, Suzanne, Samson, David J., Bonnell, Claudia J.
Published 2010
Agency for Healthcare Research and Quality
... is unfeasible or contraindicated. Currently, two rhBMPs and four associated carrier/delivery systems (one...

12
by Ratko, Thomas, Belinson, Suzanne, Samson, David J., Bonnell, Claudia J.
Published 2010
Agency for Healthcare Research and Quality
... is unfeasible or contraindicated. Currently, two rhBMPs and four associated carrier/delivery systems (one...

13
by Matchar, David B.
Published 2006
AHRQ, Technology Assessment Program
... imaging tests (NITs) for coronary artery disease. In particular, we focus on six key questions provided...